Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma

Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer. Surgery is usually curative; however, some locally advanced or metastatic CSCC may be unresectable. Current novel therapeutic options with immune checkpoint inhibition (ICI) of programmed-death receptor 1 (PD-1) such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Fei Ya, Clarke, Rachel, Cooper, Patrick, Stokes, John, Calvert, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601823/
https://www.ncbi.nlm.nih.gov/pubmed/37900839
http://dx.doi.org/10.1159/000533759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601823/
https://www.ncbi.nlm.nih.gov/pubmed/37900839
http://dx.doi.org/10.1159/000533759

Ejemplares similares